Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN

Irritable Bowel Syndrome (IBS) and Chronic ConstipationInflammatory Bowel Disease

Recommendations for the Evaluation and Management of Inflammatory Bowel Disease with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus

Gastroenterology

Ma C, Ford AC, Hashash JG, Barbara G, Bernstein CN, Brenner DM, Griffiths AM, Keefer L, Long MD, Nurko S, Singh P, Sands BE, Chang L

doi: 10.1053/j.gastro.2026.04.008

Inflammatory Bowel Disease

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN

Gastroenterology

Scarallo L, Alvisi P, Bramuzzo M, Domanico A, Kierkus J, Matar M, Strisciuglio C, De Laffolie J, Broekaert I, Aloi M, Rodríguez-Belvís MV, Renzo S, Labriola F, Tasciotti L, Dragoni G, Lionetti P

doi: 10.1053/j.gastro.2026.02.034

Inflammatory Bowel Disease

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN

J Crohns Colitis

Trivić Mažuranić I, Aloi M, Bramuzzo M, Chiantese C, D'Arcangelo G, Gattenlöhner S, Gianolio L, Granot M, Hızarcıoğlu Gülşen H, Hussey S, Kang B, Kolho KL, de Laffolie J, Lega S, Martinelli M, Matar M, Mayer C, Miele E, Norsa L, Panarese I, Rinawi F, Rohani P, Romano C, Sansotta N, Scarallo L, Shouval DS, Staiano A, Strisciuglio C, Tomas D, Yerushalmy-Feler A, Zojaji R, Hojsak I

doi: 10.1093/ecco-jcc/jjag074

COMMENTED

Inflammatory Bowel DiseaseFurther Publications

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol

Vavricka SR, Zeitz J, Madanchi M, Ruiz PA, Biedermann L, Morsy Y, Yilmaz B, Scharl M, Scharl S, Gassmann M, Lutz TA, Kunz A, Bron D, Misselwitz B, MacPherson AJ, Rogler G, Greuter T

doi: 10.14309/ajg.0000000000003888

Inflammatory Bowel Disease

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Inflamm Bowel Dis

Boute EH, Gianolio L, Mahmmod S, Pochesci S, Armstrong K, Henderson P, Wilson DC, de Ridder L, Russell RK, Escher JC

doi: 10.1093/ibd/izaf335

Further Publications

Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease

Minerva Gastroenterol (Torino)

Spagnolo G, Ferrarese D, DI Vincenzo F, Iaccarino J, Murgiano M, Vecchione M, Puca P, D'Onofrio AM, Natalello G, D'Agostino MA, Gasbarrini A, Camardese G, Chieffo DP, Scaldaferri F

doi: 10.23736/S2724-5985.26.04026-X

Inflammatory Bowel Disease

Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-week Multicenter Study from the Porto Group of ESPGHAN

Clin Gastroenterol Hepatol

Yerushalmy-Feler A, Spencer EA, Dubinsky MC, Suskind DL, Mitrova K, Hradsky O, Conrad MA, Kelsen JR, Sladek M, Yeh PJ, Tzivinikos C, Henderson P, Wlazlo M, Hackl L, Shouval DS, Mouratidou N, Bramuzzo M, Urlep D, Olbjørn C, Mancuso G, Schneider AM, Pujol-Muncunill G, Yogev D, Kang B, Gasparetto M, Rungø C, Romano C, Martinelli M, Kolho KL, Hojsak I, Norsa L, Rinawi F, Sansotta N, Rimon RM, Granot M, Scarallo L, Trindade E, Rodríguez-Belvís MV, Turner D, Cohen S

doi: 10.1016/j.cgh.2026.02.012

Inflammatory Bowel Disease

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Inflamm Bowel Dis

Lin SH, Kuo CJ, Chuang CH, Chang CW, Chung CS, Chou JW, Huang TY, Yen HH, Tsai TJ, Lin CP, Chang CH, Tai CM, Tai WC, Yao CC, Chen CC, Pan YB, Le PH

doi: 10.1093/ibd/izag150

Inflammatory Bowel Disease

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Inflamm Bowel Dis

Ricciuto A, Turinsky AL, Griffiths AM, Mack DR, Wine E, Benchimol EI, El-Matary W, Huynh HQ, Carman N, deBruyn JC, Otley AR, Church PC, Jacobson K, Low S, Broer E, Lawrence S, Sherlock M, Deslandres C, Walters TD

doi: 10.1093/ibd/izaf329

Related content

Recommendations for the Evaluation and Management of Inflammatory Bowel Disease with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease

Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-week Multicenter Study from the Porto Group of ESPGHAN

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort